Revvity Inc vs Valero Energy Corporation — how do they compare? Revvity Inc trades at $124.14 (market cap $14.18B), while Valero Energy Corporation trades at $390.5 (market cap $110.23B). The key difference: Valero Energy Corporation is far larger — about 7.8× Revvity Inc's market cap, and Valero Energy Corporation pays the higher dividend (1.25%). Which is the better fit depends on your goals.
| RVTY | VLO | |
|---|---|---|
Market Cap | $14.18B | $110.23B |
Sector | Technology | Energy |
52-Week High | $130.94 | $388.95 |
52-Week Low | $82.26 | $156.39 |
Enterprise Value | $16.50B | $113.71B |
Dividend Yield | 0.22% | 1.25% |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Valero Energy (VLO) trades at $382.85, up 3.27% with strong technical momentum and bullish moving averages. The stock shows robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and attractive valuation ratios (P/E 15.97, P/S 0.83). Recent news highlights inclusion in growth stock lists and upcoming Q3 2026 earnings on October 22, 2026.
Outlook remains positive with favorable refining conditions and analyst consensus at Buy (58%). Key risks include revenue decline from $176.4B (2022) to $122.7B (2025) and political pressure on gas prices. The stock offers value but faces sector volatility and macroeconomic headwinds.
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →